We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M Turnover 66.25%
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+14.72%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$82.1M
AUM Growth
+$6.66M
Cap. Flow
+$2.13M
Cap. Flow %
2.6%
Top 10 Hldgs %
27.02%
Holding
130
New
39
Increased
22
Reduced
26
Closed
36
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.6 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.3 years

Top Buys

Rank Stock Value
1
LBTYA icon
Liberty Global Class A
LBTYA
+$2.29M
2
MRVL icon
Marvell Technology
MRVL
+$2.07M
3
CSC
Computer Sciences
CSC
+$1.97M
4
UHS icon
Universal Health Services
UHS
+$1.75M
5
BABA icon
Alibaba
BABA
+$1.73M

Top Sells

Rank Stock Value
1
RRC icon
Range Resources
RRC
+$1.82M
2
CI icon
Cigna
CI
+$1.7M
3
WBA icon
Walgreens Boots Alliance
WBA
+$1.34M
4
CRM icon
Salesforce
CRM
+$1.33M
5
BIIB icon
Biogen
BIIB
+$1.29M

Sector Composition

Rank Sector Weight
1 Healthcare 47.04%
2 Technology 14.11%
3 Miscellaneous 13.71%
4 Communication Services 6.79%
5 Energy 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MRVL icon
1
Marvell Technology
MRVL
$217B
$2.71M 3.3%
177,687
+134,466
+311% +$2.07M
2016 Q4
1 quarter
OEF icon
2
PUT
iShares S&P 100 ETF
OEF
$20.6B
$2.58M 3.14%
+8,800
New +$909K
2017 Q1
0 quarters
LBTYA icon
3
Liberty Global Class A
LBTYA
$2.74B
$2.32M 2.83%
+64,720
New +$2.29M
2017 Q1
0 quarters
JAZZ icon
4
Jazz Pharmaceuticals
JAZZ
$13.9B
$2.3M 2.8%
15,857
-2,489
-14% -$324K
2015 Q1
8 quarters
BIIB icon
5
Biogen
BIIB
$34.8B
$2.29M 2.78%
8,363
-4,570
-35% -$1.29M
2016 Q2
3 quarters
WFT
6
DELISTED
Weatherford International plc
WFT
$2.13M 2.59%
320,408
+153,850
+92% +$902K
2016 Q4
1 quarter
CSC
7
DELISTED
Computer Sciences
CSC
$2.05M 2.5%
+29,718
New +$1.97M
2017 Q1
0 quarters
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$10.8B
$1.93M 2.35%
21,964
-2,510
-10% -$223K
2016 Q2
3 quarters
HUM icon
9
Humana
HUM
$51.9B
$1.92M 2.34%
9,315
+487
+6% +$101K
2016 Q3
2 quarters
MDCO
10
DELISTED
Medicines Co
MDCO
$1.89M 2.3%
38,703
-22,851
-37% -$1.04M
2015 Q2
7 quarters
UHS icon
11
Universal Health Services
UHS
$11B
$1.85M 2.25%
+14,847
New +$1.75M
2017 Q1
0 quarters
BABA icon
12
Alibaba
BABA
$276B
$1.83M 2.23%
+16,967
New +$1.73M
2017 Q1
0 quarters
ELV icon
13
Elevance Health
ELV
$92.9B
$1.76M 2.14%
10,637
-2,825
-21% -$449K
2016 Q4
1 quarter
XNTK icon
14
PUT
State Street SPDR NYSE Technology ETF
XNTK
$1.99B
$1.65M 2.01%
+23,800
New +$1.57M
2017 Q1
0 quarters
SBUX icon
15
Starbucks
SBUX
$110B
$1.62M 1.98%
+27,820
New +$1.57M
2017 Q1
0 quarters
PCRX icon
16
Pacira BioSciences
PCRX
$1.45B
$1.56M 1.9%
34,213
+7,523
+28% +$325K
2016 Q4
1 quarter
BAX icon
17
Baxter International
BAX
$13.3B
$1.46M 1.77%
+28,085
New +$1.38M
2017 Q1
0 quarters
GDDY icon
18
GoDaddy
GDDY
$13.6B
$1.41M 1.72%
37,287
+31,225
+515% +$1.13M
2016 Q4
1 quarter
CLVS
19
DELISTED
Clovis Oncology, Inc.
CLVS
$1.39M 1.69%
21,837
-3,772
-15% -$229K
2013 Q2
15 quarters
PTLA
20
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.39M 1.69%
35,362
+20,890
+144% +$665K
2016 Q4
1 quarter
SLCA icon
21
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$1.36M 1.65%
28,304
+10,203
+56% +$546K
2016 Q2
3 quarters
UNH icon
22
UnitedHealth
UNH
$365B
$1.24M 1.51%
7,573
-5,472
-42% -$896K
2016 Q2
3 quarters
AERI
23
DELISTED
Aerie Pharmaceuticals
AERI
$1.24M 1.51%
27,289
-4,557
-14% -$203K
2015 Q1
8 quarters
LLY icon
24
Eli Lilly
LLY
$1.12T
$1.17M 1.42%
+13,895
New +$1.11M
2017 Q1
0 quarters
TFCFA
25
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$1.13M 1.37%
+34,857
New +$1.07M
2017 Q1
0 quarters
1
2 3 4 5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Partner Investment Management held 130 positions worth $82.1M, up 8.8% from $75.5M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Partner Investment Management's Q1 2017 filing shows 39 new, 22 increased, 26 reduced and 36 closed positions. Its largest new stake was Liberty Global Class A: 64,720 shares worth $2.32M. The largest sale was Range Resources, an estimated $1.82M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 49% a quarter earlier, followed by Technology and Miscellaneous.

  • Partner Investment Management's largest Q1 2017 buy was Liberty Global Class A: 64,720 shares worth $2.32M.
  • Partner Investment Management added most to Marvell Technology in Q1 2017, an estimated $2.07M increase.
  • Partner Investment Management's biggest Q1 2017 reduction was Cigna, cutting an estimated $1.7M.
  • Partner Investment Management fully exited Range Resources in Q1 2017, selling an estimated $1.82M.
  • Partner Investment Management's ten largest holdings make up 27% of its $82.1M portfolio in Q1 2017.
  • Partner Investment Management opened 39 new positions and closed 36 in Q1 2017.
  • Partner Investment Management's portfolio value rose 8.8% quarter-over-quarter to $82.1M.

Based on Partner Investment Management's 13F filing for Q1 2017, filed 15 May 2017.